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Abstract 
Whole exome sequencing (WES) is a widely used strategy for detection of protein coding and 
splicing variants associated with inherited diseases. Many studies have shown that the 
strategy has been broad and proficient due to its ability in detecting a high proportion of 
disease causing variants, using only a small portion of the genome. In this review we outline 
the main steps involved in WES, the comprehensive analysis of the massive data obtained 
including the genomic capture, amplification, sequencing, alignment, curating, filtering and 
genetic analysis to determine the presence of candidate variants with potential 
pathogenic/functional effect. Further, we propose that the Multiple Autoimmune Syndrome 
(MAS), an extreme phenotype of autoimmune disorders, is a very well suited trait to tackle 
genomic variants of major effect underpinning the lost of self-tolerance.  
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1. Introduction 
A growing body of evidence support the involvement of rare variants (population allele 
frequency < 1%) in the aetiology of common diseases. It is possible that much of the genetic 
control of common diseases is due to rare and pathogenic variants with a major effect on the 
phenotype [1-3]. The detection of these rare genome variants harboured in coding regions has 
shown to be successfully achievable using extreme phenotypes and pedigrees segregating 
exceptional phenotypes [1-4].   
 Whole exome sequencing (WES) is a cost effective technique that employs high 
throughput capture by hybridisation techniques, using exon specific oligonucleotides to enrich 
only protein coding sequences that can be later used for sequencing [5]. The WES is rapidly 
becoming the first-line approach for monogenic disorders, and an alternative one for 
dissecting extreme phenotypes of complex inherited conditions [4,6]. Its rationale is based on 
the fact that gene variants located in exons are more likely to be pathogenic than those located 
in introns or between genes [1,4,7].  
The WES of pedigrees is a highly effective approach for identifying homozygous, 
compound heterozygous, novel, germinal, and de novo rare coding sequence variants. This is 
because multiple rare sequence variants occurring within a specific gene (or within a gene 
family or pathway) are extremely implausible events [6,7]. This concept might be applicable, 
with some restrictions, to WES of sporadic cases of very unequivocal and conspicuous 
phenotypes [2].  
Even though some estimates suggest that the success rate of uncovering variants that 
account for Mendelian disorders via exome sequencing is only 25%, this strategy is still 
arguably efficient as disease-causing protein coding variation can be located using less than 
2% of the human genome [4,7]. The comparatively low cost of this technology means that 
exome databases are rapidly expanding [7]. Therefore, there is a large abundance of this type 
of data given the access to large numbers of publicly available exome sequences which allows 
the comparison of frequencies, as well as the identification of de novo variants and the 
matching of cases and controls by ethnicity to avoid genetic stratification. Several 
manuscripts have reported the identification of candidate genes for several Mendelian and 
complex traits [2,8-11].  
Nevertheless, one must be aware of the fact that exome sequencing has deficiencies.  
This is because hybridisation probes are not available for all annotated exons within the gold 
standard databases. Also, exome sequencing will not be able to detect mutations in non-
coding DNA that alter gene function by various regulatory mechanisms and enhancer effects.  
Such variants (in recent times) are emerging as important contributors to genetic disease and 
they occur in >98% of the human genome, which is missed by exome capture [12]. For 
sequencing these non-coding regions (either intronic or inter-genic) it would be necessary 
whole genome sequencing (WGS).  
 Polyautoimmunity is defined as the presence of more than one AD in a single patient 
[13]. When three or more ADs coexist, this condition is called multiple autoimmune 
syndrome (MAS), which represents the best example of polyautoimmunity as well as the 
effect of a single genotype on diverse autoimmune phenotypes [14].  
MAS identifies a form of extreme autoimmune disorder, frequently clustering in 
families [14]. The MAS running in families often displays Mendelian segregation ratios and 
consequently represents a very potential powerful tool for identifying major genes commonly 
underpinning the development of autoimmunity [14]. Several pedigrees clustering 
polyautoimmunity and autoimmune syndromes that were ascertained from probands affecteds 
with MAS has been described [14].  
We think that these pedigrees as well as sporadic cases of MAS would be critical for 
dissecting genes of major effect conferring susceptibility to autoimmunity. Given that we 
have already demonstrated the existence of major effects and the potential location of these 
MAS loci, in this review we present a comprehensive and practical strategy of the use of 
WES to map genes implicated in extreme autoimmune phenotypes (i.e., polyautoimmunity 
and MAS). 
 
2. Whole Exome Capture and Sequencing 
In general, the next generation sequencing process works by fragmenting genomic DNA 
using sonication or mechanical shearing. The formed ends are adenylated and adaptor 
oligonucleotides are added to the ends of these adenylated fragments. These adaptors are short 
oligonucleotides of known sequences for universal priming of both amplification and 
sequencing steps [5]. Commonly, the fragments are enriched for specific genes of interest 
(targeted sequencing), or for all coding regions (whole exome capture for WES), in a physical 
capture step. That enrichment is not needed for WGS and all fragments are sequenced [5].  
Prior to the sequencing process, fragments are separated and clonally amplified by 
PCR. To do that, single strands of these fragments are then hybridised to oligo-primers on the 
genome analyser flow cell, beginning the process of cluster generation. After hybridisation 
the oligo-primers are then extended by polymerases, generating complementary strands bound 
to the same surface.  The double stranded DNA is then denatured and only newly synthesised 
strand remains as the original template is removed after washing.  The single strand molecule, 
still bound to the flow cell, then hybridises to adjacent oligo-primers and amplification 
produces a double strand ‘bridged’ molecule.  
Strands are then denatured and the bridge amplification is repeated, eventually 
generating millions of fragments. Removal of the reverse strands then leaves the forward 
strands for sequencing primers to hybridise to the oligo sequence on the template strand.  
During each cycle polymerases then extend the newly synthesised strand and in doing so 
incorporate one of 4 fluorescently labelled terminator nucleotides (ddNTP), that each have a 
blocking group on the 3 prime end. Excitation of the fluorescent dye by a laser enables 
identification of the base. Cleavage of the dye and the blocking group nucleotide from the 
fluoresecent label, allows continuation of subsequent sequencing cycles (Fig. 1). 
In terms of accuracy, Sanger sequencing is still considered by many as the gold 
standard amongst sequencing technologies that are currently available. Unlike NGS, the 
Sanger method doesn’t consist of mass cluster generation steps whilst samples are being 
prepared for sequencing. NGS is more likely to generate accumulated errors due to numerous 
amplification cycles in the bridge PCR phase [15]  
 Sanger sequencing also has the advantage of longer and more contiguous read lengths 
than most NGS technologies, thereby increasing its capability to accurately align reads and 
identify SNPs even in the presence of long repeat sequences [16]. Consequently it is 
imperative that we perform resequencing using the Sanger method, in order to check the 
validity of the chosen candidate genes and their variants.   
Another problem observed with NGS is that it is prone to sequence specific errors that result 
of secondary structure formation on single stranded DNA molecules bound to the genome 
analyser flow cell [17] (Nakamura et al 2011). Sequence-
specific error profile of Illumina sequencers. Nakamura K, Oshima T, Morimoto T, Ikeda S, 
Yoshikawa H, Shiwa Y, Ishikawa S, Linak MC, Hirai A, Takahashi H, Altaf-Ul-Amin M, 
Ogasawara N, Kanaya S. Nucleic Acids Res. 2011 Jul;39(13): 
 Examples of these include inverted repeats and GGC repetitive sequences. Inverted 
repeats inhibit bidirectional nucleotide elongation on the complementary strand for several 
cycles prior to the position of where the repeat sequence is present. This is known as lagged 
sequence contamination. With each chain reversible termination cycle, there is a delay in the 
addition of fluorescently labelled nucleotides to the synthesised strand. As the strand 
continues to grow, the secondary structure’s hydrogen bonds become destabilized and the 
reversible termination cycles for each sequence eventually resumes at normal speed. However 
by this stage of the sequencing phase, it is likely that many reads proximal to the repeat region 
will falsely report a variant base due to the effects of lagged sequence contamination in 
previous cycles [17]. (Nakamura et al 2011, see above).  
GGC repeat sequences have a similar effect, but it is hypothesised that this sequence 
repeat preferentially binds to DNA polymerase to inhibit the synthesis process. However the 
exact mechanism is not well understood. Nevertheless it was also found in the same study 
[17] (Nakumara et al 2011, see above), that 10% sequence specific errors were not associated 
with these inverted repeats or GGC repeats. Thus other secondary structures could also 
contribute to sequencing errors and inaccurate variant calls. This provides extra incentive to 
conduct resequencing as a means of follow up SNP validation. Also it is essential to look 
towards improved NGS technologies and advanced variant calling software to mitigate these 
problems. 
 
3. Bioinformatics Analysis  
DNA sequence of each individual obtained from exome capture is processed through a variant 
calling pipeline containing custom PERL scripts developed by the Immunogenomics Lab 
Bioinformatics team. Sequence reads are aligned to the latest version of the reference human 
genome, using the alignment algorithm (BWA or Burrrows Wheel Aligner) developed by 
[18]. The output alignment file and its index are compressed into a binary file. Often during 
the PCR amplification stage of library preparation, duplicate reads are produced as a result of 
amplification bias, i.e. multiple copies of the same DNA fragment can be placed on different 
primers along the flow cell. Assuming that these reads contain the same sequence content and 
align to the same region, they can be selectively removed by the pipeline’s algorithms. This is 
done to ensure that variants are not called as a result of these sequencing artefacts [19] (Fig. 
2). 
 The output of the BWA alignment step (which includes the alignment index and 
alignments in binary format) is used as a template by a set of bioinformatics utilities (known 
as SAMtools) for alignment viewing and variant calling [20]. Variants are filtered by the 
pipeline in accordance to the following criteria: 
• Variants in the sequenced exomes that overlap dbSNP variants are annotated along 
with the dbSNP population frequency.   
• The SNP score is an indication of the level of confidence that a variant is present in a 
given nucleotide position. An arbitrary cut-off score of 40 is set for this purpose. 
• The variants are then overlapped with the ENSEMBL database, in order to identify 
which variants fall within coding exons and splice sites (defined as 10bp outside the 
exon boundary). Based on previous empirical data, it has been indicated that splice 
mutations within 10bp from exons have a lower density of SNPs. This suggests that 
there may be high levels of sequence conservation in these genomic regions as a result 
of selection pressure [21] (Fairbrother et al 2004). Therefore, splice variants 1-10 
bases from exon boundaries are also considered as potentially causative mutations, 
along with non-synonymous SNPs. 
 
Genetic variants are filtered and prioritised using a heuristic system using several tools 
calculating the amino acid substitution effects on the structure and function of the protein, for 
all non-synonymous variants within genes.  Using many algorithms from externally available 
databases, each variant is scored and classified, based on the protein region in which the 
amino acid substitution has taken place.  Some of these algorithms include: 
3.1. Uniprot  
When a query amino acid sequence of a protein is submitted to Uniprot 
(http://www.uniprot.org), the software can search the uniprot database annotations, which 
indicate whether the substitution took place at a transmembrane domain, carbohydrate 
molecule, lipid side chain, etc. [22]. 
 
3.2. PSIC (Position Specific Independent Counts) profiles  
PSIC computes the likelihood ratio that any given variant amino acid is likely to be found at a 
particular position in the protein vs. the likelihood of observing the same amino acid at any 
other position  (http://www.imb.ac.ru/PSIC) [23]. This calculation is based on the sequence 
conservation of protein sequences determined after PolyPhen2 aligns to and identifies 
homologous sequences from BLAST (Basic Local Alignment Search Tool) search of the 
UniRef 100 database. PSIC profiles are generated for sequence homologues that are longer 
than 50 residues in length and have a sequence identity of 30-94%. Large differences in the 
PSIC probability profile scores between the wild type amino acid and the variant amino acid, 
indicate that substitutions in a given protein region are rare. This indicates that amino acid 
sequences in the protein have a high level of conservation, suggesting that substitutions in 
these regions are likely to be deleterious [22,23]. 
 
3.3. Ramachadran Plots.  
These plots measure the change in the dihedral angle within sections of the 3D structure of the 
protein as a result of an amino acid substitution.  The change in dihedral angles (as a result of 
amino acid substitutions) in these plots are measured the C’ (carbonyl carbon)-N-Ca (alpha 
carbon)-C’ backbone and the N-Ca –C’-N backbone in the protein’s secondary structure [24]. 
Information about the 3D protein structures can be obtained from the Dictionary of Secondary 
Structure Proteins (DSSP) [25].  
 
3.4. PolyPhen (http://genetics.bwh.harvard.edu/pph2/) and SIFT (Sorting Intolerant 
from Tolerant) scores (http://sift.bii.a-star.edu.sg).  
These tools are similar in the sense that are designed to achieve the same outcome, and rely 
on sequence conservation. They use a normalized position specific scoring matrix, i.e. it 
calculates probability that the amino acid, will change states to another particular amino acid, 
based on the level of conservation in the protein family.  Those with low transition 
probabilities, due to highly conserved residues are predicted to be deleterious [26]. However, 
unlike PolyPhen, SIFT doesn’t implement information from the 3D or secondary structures of 
proteins.   
Thus using all these incorporated criteria, we scored the amino acid substitution and 
then prioritised as benign, tolerated possibly damaging, deleterious or probably damaging. 
Variants with ‘benign’ and ‘tolerated; amino acid changes can be excluded during the 
filtration process.	  
	  
3.5. Variant Population Frequency Obtained from the dbSNP Database.  
The population frequencies of variants (SNPs and INDELs) annotated in the variant calling 
pipeline were obtained from the dbSNP archives. As mentioned earlier, this database contains 
known genetic variation, obtained from genome sequencing and variant haplotyping of 
individuals from different ethnic groups. Hence the dbSNP population frequencies for all 
SNPs and INDELs obtained from the variant calling pipeline were used as a quantitative 
guide for identifying variants that were rare and common amongst the worldwide population. 
Given the nature of the design that uses extreme phenotypes, common variants are discarded, 
as the effect size provided by them must be small. 
 
4. Network Building Algorithms and Pathway Analysis for Filtered Gene List 
After applying the filtration steps described above, the refined gene list was then used as an 
input source for functional network and pathway analysis algorithms as implemented in 
Metacore®. In it, the network and pathway analysis algorithms are available through a web 
interface, and the software suite also includes a manually curated gene ontology database. The 
algorithm to build these networks incorporates our input gene list into a single dense network.  
This is known as a ‘global network’, which is then divided into biologically functional sub-
networks.  Within these networks, each node (connected by 2 or more genes) is represented 
by a subset of gene ontology processes. These can be used in a heuristic manner to identify 
genes with important functions in autoimmunity.  
The ontology terms for a gene (which is connected to other genes via network nodes) 
within the networks are prioritized by the likelihood of overrepresentation that are calculated 
based on the size of the intersection between the input gene list and the network process in 
question. In other terms, the statistical probability that a given number of genes from the input 
gene list would randomly overlap with a particular GeneGo ontology process.  
 The only nodes used for statistical evaluations only include those with direct physical 
interactions with our input dataset (i.e. our gene list generated from the filtration strategies 
described above).  This is done to help minimize artefacts in the statistical analysis, which can 
arise from genes in the database, which may be in the same network, but have no functional 
connection or interaction with any gene from the input list. 
 
5. Conclusions 
Whole-exome capture and sequencing analysis is a time and resource-intense endeavor. 
Currently, we employ software that allows rapid selection of any genetic variant according to 
variant type, novelty (via screening public and private databases), and predicted protein effect.  
However, linking these results to phenotypic manifestations in a particular person is currently 
performed by a mixture of manual analysis using a number of additional databases (e.g., 
Human Genome Mutation Database, OMIM, PubMed, and UCSC, among others). We built 
on existing analytic tools in order to rapidly detect and annotate genomic variants associated 
with human disease. We are aware that analytical criteria for filtering need to be flexible and 
up-to-date; therefore, we undertook a systematic upgrade and iterative processes of the 
databases evaluation by considering each filter. 
JuanMa: Can you introduce something about MAS and its importance.  
Take Home Messages 
1. Based on data from recent studies, exome capture can be considered as a feasible 
and effective strategy to detect potentially causative variants in autoimmunity. 
2. Variant detection is enhanced by Next Generation Sequencing technology , which 
provides enhanced sequencing chemistry and parallelization of DNA samples.  
3. In addition to improvements in sequencing, more powerful bioinformatics tools 
are available  to determine the association with and potential functional 
significance of candidate genetic variants in autoimmunity. 	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Legends to the Figures  
Figure 1. Main steps of next-generation sequencing for whole genome and exome 
sequencing. Extracted DNA is broken into <1000 bp fragments and adaptor sequences (in 
green and red) are ligated to fragments. In whole-genome sequencing, all fragments are 
sequenced. In whole-exome and targeted sequencing only a subset of the original fragment 
pool is sequenced. Fragments are separated on a slide and clonal amplification by PCR to 
generate fragment clusters. Four fluorescently labeled nucleotides are added to the slide and 
compete to be incorporated to the growing chains. In each cycle, the clusters are excited by 
laser and the emitted fluorescence (colored circles) is recorded by an image-capturing device.  
 
Figure 2. Bioinformatics algorithm for aligning, curating, and filtering of data obtained from 
next generation sequencing. The genetic analysis for candidate pathogenic variants can be 
performed by classical association and/or linkage analysis if variants are common, or by 
collapsing methods as the Kernel Based Adaptive Cluster (KBAC), in the case of rare ones 
(those with a minor allele frequency < 1% in the population.   
